Johannes L Peterse
Overview
Explore the profile of Johannes L Peterse including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
4902
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schmitz A, van den Bosch M, Loo C, Mali W, Bartelink H, Gertenbach M, et al.
Radiother Oncol
. 2010 Sep;
97(2):225-32.
PMID: 20826026
Background: Magnetic resonance imaging (MRI) is more often considered to guide, evaluate or select patients for partial breast irradiation (PBI) or minimally invasive therapy. Safe treatment margins around the MRI-visible...
2.
Jones H, Antonini N, Hart A, Peterse J, Horiot J, Collin F, et al.
J Clin Oncol
. 2009 Sep;
27(30):4939-47.
PMID: 19720914
Purpose: To investigate the long-term impact of pathologic characteristics and an extra boost dose of 16 Gy on local relapse, for stage I and II invasive breast cancer patients treated...
3.
Joosse S, van Beers E, Tielen I, Horlings H, Peterse J, Hoogerbrugge N, et al.
Breast Cancer Res Treat
. 2008 Aug;
116(3):479-89.
PMID: 18704682
Background: While new defects in BRCA1 are still being found, it is unclear whether current breast cancer diagnostics misses many BRCA1-associated cases. A reliable test that is able to indicate...
4.
Keyzer-Dekker C, Houtkamp R, Peterse J, Van Coevorden F
Sarcoma
. 2008 Jun;
8(1):19-24.
PMID: 18521389
Introduction. Adult pelvic soft tissue sarcomas are a rare group of heterogeneous malignancies. These sarcomas differ from extremity and trunk soft tissue sarcomas in presentation, characteristics and response to treatment.Methods....
5.
Cleton-Jansen A, van Eijk R, Lombaerts M, Schmidt M, Vant Veer L, Philippo K, et al.
BMC Cancer
. 2008 Apr;
8:105.
PMID: 18416817
Background: Loss of heterozygosity (LOH) at chromosome arm 16q is frequently observed in human breast cancer, suggesting that one or more target tumor suppressor genes (TSGs) are located there. However,...
6.
Lee C, Espinosa I, Vrijaldenhoven S, Subramanian S, Montgomery K, Zhu S, et al.
Clin Cancer Res
. 2008 Mar;
14(5):1423-30.
PMID: 18316565
Purpose: Macrophages are migratory cells that are frequently recruited to the site of tumors. Their presence is associated with poor clinical outcome in a variety of epithelial malignancies. The aim...
7.
Kok M, Linn S, van Laar R, Jansen M, van den Berg T, Delahaye L, et al.
Breast Cancer Res Treat
. 2008 Mar;
113(2):275-83.
PMID: 18311582
Background: Molecular signatures that predict outcome in tamoxifen treated breast cancer patients have been identified. For the first time, we compared these response profiles in an independent cohort of (neo)adjuvant...
8.
Bueno-de-Mesquita J, van Harten W, Retel V, J van t Veer L, van Dam F, Karsenberg K, et al.
Lancet Oncol
. 2007 Nov;
8(12):1079-1087.
PMID: 18042430
Background: A microarray-based 70-gene prognosis signature might improve the selection of patients with node-negative breast cancer for adjuvant systemic treatment. The main aims of this MicroarRAy PrognoSTics in Breast CancER...
9.
Meijnen P, Oldenburg H, Peterse J, Bartelink H, Rutgers E
Ann Surg Oncol
. 2007 Nov;
15(1):235-43.
PMID: 17987342
Background: The effect of treatment of patients diagnosed with ductal carcinoma in situ (DCIS) of the breast was evaluated, and factors associated with local recurrence were assessed. Methods: The study...
10.
Hayes M, Peterse J, Yavuz E, Vischer G, Eusebi V
Am J Surg Pathol
. 2007 Aug;
31(9):1414-9.
PMID: 17721198
Three cases of squamous carcinoma in situ of the breast, one with an invasive component are described in women aged 35, 51, and 59 years. Two cases were detected by...